Since 2019, the Health 10x Accelerator has supported Australia's brightest health and medtech entrepreneurs in developing affordable and scalable solutions to the world's most pressing unmet health and medical needs. Delivered in partnership with UNSW, the 10-week program provides startups with funding, mentorship, and resources to navigate regulatory pathways, refine investment strategies, and scale globally. Key partners and supporters, including Virtus Health, UNSW Tyree Institute of Health Engineering (IHealthE), Platypus MedTech Consulting, Genesys Electronics Design, Randwick Health & Innovation Precinct, Liverpool Innovation Precinct and AstraZeneca, offer additional support in coaching, investment, and specialised expertise. With the support of our partners and collaborators, startups can gain access to state-of-the-art facilities, collaboration spaces, and commercialisation specialists, enhancing their ability to create impactful solutions that transform global health outc

High blood pressure (hypertension) is the leading preventable cause of death, driving millions of heart attacks, strokes and cases of dementia and kidney disease every year. It occurs when the pressure in the blood vessel walls is consistently too high and may be driven by behaviours we can change (e.g. diet, alcohol intake and inactivity) and factors we cannot (e.g. family history, age and ethnicity). Certain medical conditions may also increase the chance of developing high blood pressure, such as obesity, diabetes and kidney disease. Despite the serious risks, high blood pressure is often overlooked. It’s called a ‘silent killer’ as there are usually no symptoms. Around 1.4 billion adults are living with high blood pressure globally - around three-quarters in low- and middle-income countries - yet an estimated 600 million people don’t even know they have it. Without action, fewer than a quarter of people with high blood pressure will ever have it under control. This crisis is

1. About us The George Institute for Global Health, together with its subsidiary companies worldwide (The George Institute or TGI), is committed to the highest standards of conduct and ethical behaviour, research integrity and good corporate governance and to operating: legally and in accordance with applicable legislation and regulations; properly, in accordance with organisational policy and procedures; and ethically, in accordance with recognised ethical principles. Including: supporting Whistleblowers to make reports based on reasonable grounds of Reportable Conduct involving the Institute’s activities, including its scientific research; ensuring that any Whistleblower who makes a report based on reasonable grounds to assist in maintaining the legal, proper and ethical operations of the Institute, can do so: anonymously if they wish; without fear of intimidation, disadvantage or reprisal; and without being penalised in any w

Real change happens when people come together. Join a global community dedicated to improving health worldwide.